Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zoll Medical AED Plus

This article was originally published in The Gray Sheet

Executive Summary

Automated external defibrillator shipments are expected to begin this summer following 510(k) clearance, announced March 26. Zoll's first offering for the public access defibrillator market, the device incorporates Rectilinear Biphasic waveform technology and also is the first AED to feature a single electrode pad and run on off-the-shelf batteries, according to Zoll. A patent infringement suit filed by competitor Cardiac Science March 28 in California federal court relates to Cardiac Science's '919 and '299 patents for electrode packaging and sensor technology, and seeks an injunction on sales and unspecified damages. Zoll says it is "confident that the AED Plus does not infringe these patents"...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016357

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel